Sindayigaya, Rémy
Dogan, Can
Demtröder, Cédric Remy
Fischer, Britta
Karam, Elias
Buggisch, Jonathan Robin
Tempfer, Clemens B.
Lecomte, Thierry
Ouaissi, Mehdi
Giger-Pabst, Urs
Article History
Received: 17 May 2021
Accepted: 4 August 2021
First Online: 5 October 2021
Disclosure
: Thierry Lecomte has received payments for clinical research/scientific work from Sanofi Genzyme and Merck; he is a consultant and expert for Sanofi Genzyme; he has conducted courses and training for Merck, Amgen and Lilly. He has received invitations to national and international congresses from Amgen and Servier. All other authors have no conflicts of interest or financial ties to disclose.